Resources for Occupational Safety and Health Administration (OSHA)

FDA Advisory Committee OKs Psoriasis Drug Enbrel For Pediatric Use

www.allheadlinenews.com

A U.S. Food and Drug Administration (FDA) advisory panel on Wednesday recommended the psoriasis drug Enbrel to be approved for pediatric use with moderate-to-severe forms of the skin disease.

Seven panel members from the advisory committee voted in favor of recommending approval while five voted against and one abstained. The panel said the drug appears effective but expressed concerns about increased risks of malignancy and serious infections like tuberculosis.

Although the FDA generally follows the advice of its panels, which are composed of outside medical experts, it is not mandatory for it to do so.

View the Resource

Share or bookmarklet this web page at: